Nuvation Bio Inc.
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Nov 4, 2026 (8 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 30, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| Sep 16, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Sep 16, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Aug 21, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| Aug 18, 2026 | JP Morgan | initiate | — → Overweight | — | 55% |
| Aug 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 27, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 23, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Jul 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 55% |
| May 5, 2026 | RBC Capital | reiterate | Outperform → Outperform | — | 55% |
| May 5, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| May 5, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 16, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Apr 2, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Mar 27, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Mar 3, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Mar 3, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Feb 10, 2026 | Wedbush | reiterate | Outperform → Outperform | $11 | 58% |
| Jan 21, 2026 | RBC Capital | maintain | Outperform → Outperform | $12 | 55% |
| Jan 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $17 | 44% |
| Jan 7, 2026 | UBS | initiate | — → Neutral | $10 | 54% |
| Dec 11, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $18 | 44% |
| Dec 1, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Nov 24, 2025 | Truist Securities | initiate | — → Buy | $11 | 55% |
| Nov 20, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $10 | 47% |
| Nov 19, 2025 | B. Riley Securities | initiate | — → Buy | $12 | 54% |
| Nov 4, 2025 | RBC Capital | maintain | Outperform → Outperform | $8 | 55% |
| Nov 4, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $8 | 47% |
| Oct 13, 2025 | Wedbush | reiterate | Outperform → Outperform | $6 | 58% |
| Sep 30, 2025 | Jefferies | initiate | — → Buy | $10 | 52% |
| Sep 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Sep 8, 2025 | Wedbush | reiterate | Outperform → Outperform | $6 | 58% |
| Aug 8, 2025 | RBC Capital | maintain | Outperform → Outperform | $7 | 55% |
| Jun 25, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $6 | 53% |
| Jun 17, 2025 | RBC Capital | maintain | Outperform → Outperform | $6 | 55% |
| Jun 11, 2025 | Wedbush | maintain | Outperform → Outperform | $5 | 58% |
| Jun 2, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $6 | 53% |
| May 16, 2025 | Wedbush | reiterate | Outperform → Outperform | $5 | 58% |
| Apr 23, 2025 | JMP Securities | initiate | — → Market Outperform | $6 | 53% |
| Mar 12, 2025 | Jones Trading | initiate | — → Buy | $10 | 50% |
| Mar 10, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Jan 23, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $11 | 44% |
| Jan 22, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $11 | 44% |
| Jan 7, 2025 | RBC Capital | reiterate | Outperform → Outperform | $10 | 55% |
| Jan 6, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Nov 7, 2024 | RBC Capital | maintain | Outperform → Outperform | $6 | 55% |
| Oct 22, 2024 | Wedbush | reiterate | Outperform → Outperform | $5 | 58% |
| Sep 16, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Sep 11, 2024 | Wedbush | reiterate | Outperform → Outperform | $5 | 58% |
No cross-platform signals in the last 90 days